Susquehanna International Group
SBFM

Susquehanna International Group’s Sunshine Biopharma SBFM Stock Holding History

Susquehanna International Group’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-385
Closed -$32.1K – 12906
2024
Q2 		$32.1K Buy
+385
New +$183K ﹤0.01% 11546
2022
Q4 		– Sell
-1
Closed -$11K – 13524
2022
Q3 		$11K Buy
+1
New +$21.7K ﹤0.01% 12762

Other funds holding SBFM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Susquehanna International Group's SBFM Position: Q3 2024 in Review

Susquehanna International Group sold out of Sunshine Biopharma (SBFM) in Q3 2024, closing a stake of 385 shares — an estimated $32.1K sold.

Susquehanna International Group first reported a position in SBFM in Q3 2022 and held it in 2 quarters. The position peaked at $32.1K in Q2 2024. 3 funds tracked by Wall St. Rank hold SBFM as of Q3 2024.

  • Susquehanna International Group reported no remaining Sunshine Biopharma position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 385 Sunshine Biopharma shares in Q3 2024, an estimated $32.1K.
  • Susquehanna International Group first reported a position in Sunshine Biopharma in Q3 2022 and held it in 2 quarters.
  • Susquehanna International Group's Sunshine Biopharma position peaked at $32.1K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.